Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Novo Nordisk A/S
NOVO-BCurrent price
973.3 DKK
-7 DKK (-0.71%)
Last closed
980.3 DKK
Company
www.novonordisk.com
Sector
Healthcare
Industry
Biotechnology
Exchange
Copenhagen Exchange
Capitalization
4 362 986 061 826 DKK
Yield for 12 month
-9.21 %
1Y
3Y
5Y
10Y
15Y
NOVO-B
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Alle 1, Bagsvaerd, Denmark, 2880
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6 544.83 DKKP/E ratio
49.2312Dividend Yield
1.31 %Current Year
+232 260 999 998 DKK
Last Year
+176 954 000 001 DKK
Current Quarter
+65 349 000 003 DKK
Last Quarter
+65 863 000 002 DKK
Current Year
+196 495 999 997 DKK
Last Year
+148 506 000 002 DKK
Current Quarter
+55 433 000 002 DKK
Last Quarter
+55 848 999 998 DKK
Key Figures NOVO-B
1 year
3 years
5 years
10 years
EBITDA
117 846 999 040 DKK
Operating Margin TTM
PE Ratio
49.2312
Return On Assets TTM
25.24 %
PEG Ratio
2.4422
Return On Equity TTM
99.87 %
Wall Street Target Price
6 544.83 DKK
Revenue TTM
244 243 005 440 DKK
Book Value
22.18 DKK
Revenue Per Share TTM
Dividend Share
9.4 DKK
Quarterly Revenue Growth YOY
22.5 %
Dividend Yield
1.31 %
Gross Profit TTM
148 506 000 000 DKK
Earnings per share
19.9 DKK
Diluted Eps TTM
19.9 DKK
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
29.4 %
Profit Margin
36.55 %
Dividend Analytics NOVO-B
Dividend growth over 5 years
80 %Continuous growth
–Payout Ratio 5 years average
31 %Dividend History NOVO-B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
12.8
Ex Dividend Date
22.03.2024
Forward Annual Dividend Yield
1.31 %
Last Split Factor
2:1
Payout Ratio
38.81 %
Last Split Date
13.09.2023
Dividend Date
–
Stock Valuation NOVO-B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
49.2312
Forward PE
38.3142
Enterprise Value Revenue
16.891
Price Sales TTM
16.9048
Enterprise Value EBITDA
34.2244
Price Book MRQ
36.8459
Financials NOVO-B
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NOVO-B
For 52 weeks
518.89 DKK
1 033.2 DKK
50 Day MA
949.86 DKK
Shares Short Prior Month
–
200 Day MA
811.68 DKK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart